Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells

Japanese Journal of Cancer Research

Volumn 85, Issue 9, 1994, Pages 966-971

  Minagawa, Yukihisa ^a   Kigawa, Junzo ^a   Ishihara, Hiroshi ^a   Itamochi, Hiroaki ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

CDDP; CPT 11; HeLa cell; resistance

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BUTHIONINE SULFOXIMINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLUTATHIONE; IRINOTECAN; MIBOPLATIN; NEDAPLATIN;

ARTICLE; CANCER; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; METABOLITE; PRIORITY JOURNAL;

CAMPTOTHECIN; CISPLATIN; DRUG RESISTANCE; ETOPOSIDE; GLUTATHIONE; HELA CELLS; HUMAN; IN VITRO; METHIONINE;

EID: 0027965156     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1994.tb02976.x     Document Type: Article

References (26)

1. Cisplatin
2. Chemotherapy of ovarian cancer
3. Molecular basis of cisplatin resistance in human carcinomas: model systems and patients
4. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance
5. Inhibitors of DNA topoisomerases
6. cis‐Dichlorodiammineplatinum(II): combination chemotherapy and cross‐resistance studies with tumors of mice
7. Progress in chemotherapy for non‐small cell lung cancer
8. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin
9. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme‐DNA complex
10. Antitumor activity of 7‐ethyl‐10‐[4‐(1‐piperidino) ‐1 ‐piperidino]carbonyloxycamptothecin, a novel water‐soluble derivative of camptothecin, against murine tumors
11. Antitumor effect of CPT‐11, a new derivative of camptothecin, against pleiotropic drug‐resistant tumors in vitro and in vivo
12. Metabolism and pharmacokinetics of the camptothecin analogue CPT‐11 in the mouse
13. Intracellular roles of SN‐38, a metabolite of the camptothecin derivative CPT‐11, in the antitumor effect of CPT‐11
14. Effects of CPT‐11 in combination with other anti‐cancer agents in culture
15. CPT‐11 in combination with cisplatin for advanced non‐small‐cell lung cancer
16. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
17. Determination of glutathione and glutathione disulfide using glutathione reductase and 2‐vinyl‐pyridine
18. Potentiation of melphalan cytotoxicity in human ovarian cell lines by glutathione depletion
19. Protein measurement with the Folin phenol reagent
20. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
21. Effect of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture
22. Enhanced host cell reactivation of damaged plasmid DMA in HeLa cells resistant to cis‐diamminedichloro‐platinum(II)
23. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin
24. Accumulation of cis‐diamminedichloroplatinum(II) and its analogues in sensitive and resistant human ovarian carcinoma cells
25. CPT‐11: a new derivative of camptothecin for the treatment of refractory or relapsed small‐cell lung cancer
26. Mechanism of cross‐resistance to camptothecin analogue (CPT‐11) in a human ovarian cancer cell line selected by cisplatin